A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was that whether patients who are dependent on chronic dialysis have higher morbidity and mortality rates than the general population when undergoing cardiac surgery. These patients often require surgery in view of their heightened risk of cardiac disease. Altogether 278 relevant papers were identified using the below mentioned search, 16 papers represented the best evidence to answer the question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses were tabulated. Dialysisdependent (DD) patients undergoing coronary artery bypass grafting (CABG) or valve replacement have higher morbidity but acceptable outcomes. There is some evidence to show that outcomes after off-pump coronary artery bypass grafting (OPCAB) are better than after on-pump coronary artery bypass grafting (ONCAB) and that results are worse in DD patients with diabetic nephropathy. Patients undergoing combined procedures have a higher mortality.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in ICVTS [1] .
CLINICAL SCENARIO
A 52-year old man with chronic dialysis presents with increasing angina on exertion and dyspnoea. Coronary angiogram showed severe three-vessel disease and a transthoracic echocardiogram showed severe aortic stenosis with good left ventricular systolic function. The patient asks about the outcome of cardiac surgery in end-stage renal disease. Therefore, you resolve to search the literature to find the best evidence. 
THREE-PART QUESTION

SEARCH STRATEGY
Medline was searched, all dates until December 2012 included. Search terms; (outcomes) AND (cardiac surgery) AND (dialysis).
SEARCH OUTCOME
Two hundred and seventy-eight papers were returned using the above search, 16 of which were identified as being suitable for inclusion in this BET (Table 1) .
RESULTS
Of the sixteen papers included [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , only 1 is a prospective study and the rest retrospective. Powell et al. [2] performed a prospective nested case-control study involving 28 dialysis-dependent (DD) patients with end-stage renal disease (ESRD) undergoing coronary artery bypass grafting (CABG) matched with 84 patients without ESRD. This paper focused on short-term outcomes, and showed that the only difference was in the total length of hospitalization (15 ± 16 days in DD patients compared with 7 ± 3 days in the non-DD (NDD) group [21% longer]). Hence, the paper concluded that CABG can be performed as safely in DD patients as in NDD patients. Charytan et al. [3] studied DD patients included in the 2001 National Inpatient Sample in the USA, involving 635 DD patients and 77 323 NDD patients undergoing CABG. They found that in-hospital death was 3.38 times more likely in DD patients, and these patients were more likely to develop a stroke, pneumonia or sepsis and have a longer hospital stay. Predictors of in-hospital death were coexisting congestive heart failure, valvular heart disease, and neurological disorders. Horai et al. [4] studied Peri-op mortality and morbidity not significantly different in diabetic nephropathy dialysis patients than in non-diabetic nephropathy haemodialysis patients. Diabetic nephropathy has no effect on late patient survival or late cardiac events OPCAB and the rest conventional CABG (ONCAB). This study showed that the morbidity was significantly higher (47.8%) in the on-pump coronary artery bypass grafting (ONCAB) group compared with OPCAB (8.3%). Zhang and co-workers [7] performed a study looking at in-hospital outcomes of DD patients, 168 of whom underwent OPCAB and 126 ONCAB over a 5-year period. The OPCAB group had significantly lower in-hospital mortality compared with the ONCAB group (5.4 vs 11.9%, respectively). Logistic regression identified cardiopulmonary bypass as an independent risk factor for mortality and myocardial infarction and overall survival was similar. Beckermann et al. [8] carried out an analysis of DD patients, 21 undergoing OPCAB and 16 ONCAB. They found that the incidence of new-onset atrial fibrillation was lower in OPCAB (4.8%) vs ONCAB (37.5%). The same paper also looked at patients undergoing CABG over a two year period on the United States Renal Data System (3382 ONCAB and 540 OPCAB). Although survival curves at 18 months were similar, the Cox model showed that all-cause mortality was reduced by 16% with OPCAB vs ONCAB. Kinoshita and co-workers [15] looked at 56 DD patients, 32 underwent OPCAB with bilateral internal thoracic artery grafts (BITA) and 23 single internal thoracic artery grafts (SITA). The BITA group had a 6.3% 30-day mortality compared with 13.0% in the SITA group with no difference in sternal wound infection. Nakatsu et al. [16] performed a study on the long-term outcomes in DD patients undergoing CABG using BITA or SITA over a 21-year period. Forty-nine patients underwent BITA and 81 SITA grafting. There was no significant outcome differences other than in non-diabetic patients who had fewer cardiac events following CABG with BITA grafting [16] .
Continued
Hirose and co-workers [9] studied DD patients (n = 52) undergoing cardiac surgery, comparing patients diabetic nephropathy with those with non-diabetic nephropathy. Diabetic nephropathy patients had longer period of intubation, ICU and hospital stay. Hosoda et al. [10] also studied the outcomes of diabetic nephropathy vs non-diabetic nephropathy in CABG patients (n = 45). They found that the diabetic group were more likely to have pre-existing vascular disorders and the long-term outcomes were better in patients with non-diabetic nephropathy. Kaplon et al. [11] identified 42 DD patients at the Cleveland Clinic who underwent aortic (AVR) or mitral valve replacement (MVR) between 1986 and 1997. Four patients who received mechanical prosthesis and 1 who received bioprosthesis group required further surgery for endocarditis or valve failure. Patients with bioprosthesis did not experience accelerated calcification and they showed that valve replacement does not reduce survival time of DD patients. Tanaka et al. [13] carried out a study to see whether DD patients could be treated when undergoing AVR in the same way as NDD patients with satisfactory outcomes. They studied 72 DD patients who underwent AVR (51 mechanical and 22 bioprosthetic) and observed the complication rate. There was a statistically significant difference in age between the groups, with elderly patients more frequently receiving bioprosthetic valves. The mechanical valve group had 12 valve-related complications compared with 2 patients from the bioprosthetic group. The study concluded that AVR could be carried out with satisfactory results in DD patients and that the type of valve material should be selected on an individual basis.
CLINICAL BOTTOM LINE
DD patients undergoing CABG or valve replacement have higher morbidity but acceptable outcomes. There is some evidence to show that the outcomes after OPCAB are better than after ONCAB and that outcomes are worse in DD patients with diabetic nephropathy. Patients undergoing combined procedures have a higher mortality. However, prospective studies reporting outcomes in DD patients undergoing cardiac surgery remains fairly limited.
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